AI assistant
Dermata Therapeutics, Inc. — Director's Dealing 2021
Aug 13, 2021
35467_dirs_2021-08-12_9c15efdf-a675-49f0-b17e-2d3756361c9a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Dermata Therapeutics, Inc. (DRMA)
CIK: 0001853816
Period of Report: 2021-08-12
Reporting Person: Nardo Christopher J. (Senior VP, Development)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 25121 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $5.74 | 2031-03-31 | Common Stock (1585) | Direct | |
| Stock Option (Right to Buy) | $5.74 | 2031-03-31 | Common Stock (2439) | Direct | |
| Stock Option (Right to Buy) | $5.74 | 2031-03-31 | Common Stock (6097) | Direct | |
| Stock Option (Right to Buy) | $5.74 | 2031-03-31 | Common Stock (6097) | Direct | |
| Stock Option (Right to Buy) | $5.74 | 2031-03-31 | Common Stock (24390) | Direct | |
| Stock Option (Right to Buy) | $5.74 | 2031-03-31 | Common Stock (24390) | Direct | |
| Series 1 Preferred Stock | $ | Common Stock (50000) | Indirect |
Footnotes
F1: Shares reported reflect the 1 for 20.5 stock split effected July 1, 2021.
F2: Options vest in 48 equal monthly installments commencing September 1, 2017.
F3: Options vest in 48 equal monthly installments commencing January 1, 2018.
F4: Options vest in 48 equal monthly installments commencing December 19, 2018.
F5: Options vest in 48 equal monthly installments commencing December 11, 2019.
F6: Options vest in 48 equal monthly installments commencing January 1, 2021.
F7: The Series 1 Preferred Stock is convertible into shares of Common Stock in connection with the Issuer's initial public offering ("IPO"). All shares of Series 1 Preferred Stock will be converted into 2,439 shares of Common Stock of the Issuer upon consummation of the IPO. The conversion ratio reflects the Stock Split.
F8: Reporting person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.